RxDoctor Payments DataLook up a doctor →

Raymond Kurker, MD

Family Medicine · South Windsor, CTNPI 1003966342

Payments from drug & device makers

$106,600in general payments, 2019–2025

Across 2,249 payments — averaging $47.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$61K
  • Phathom Pharmaceuticals, Inc.$9K
  • AstraZeneca$4K
  • GSK$4K
  • Novo Nordisk$3K
  • Pfizer$2K
  • plus $24K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)406$60,509
Phathom Pharmaceuticals, Inc.24$8,639
AstraZeneca126$4,312
GSK185$4,110
Novo Nordisk139$2,908
Pfizer132$1,964
Amgen(2 entities)99$1,647
Teva Pharmaceuticals USA, Inc.95$1,473
Sanofi-aventis U.S. LLC58$1,335
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)54$1,265
Lilly USA, LLC70$1,263
Boehringer Ingelheim52$1,178
Abbott41$987
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC57$977
Otsuka America Pharmaceutical, Inc.42$967
Johnson & Johnson(2 entities)41$837
Arbor Pharmaceuticals, Inc.65$776
Bayer28$725
Bausch Health US, LLC50$706
Astellas Pharma US Inc28$695
Novartis22$549
Alkermes, Inc.25$530
Lundbeck LLC46$515
Corcept Therapeutics20$503
Merck24$463
Amarin Pharma, Inc.23$441
Biohaven Pharmaceutical Holding Company Ltd.27$417
Exact Sciences21$408
Azurity Pharmaceuticals, Inc.19$354
Antares Pharma, Inc.7$352
QOL Medical, LLC17$294
Biohaven Pharmaceuticals, Inc.15$255
Axsome Therapeutics, Inc.7$251
Eisai Inc.9$231
Therapeuticsmd, Inc.10$223
Incyte Corporation7$219
Ardelyx, Inc.5$178
E.r. Squibb & Sons, L.L.C.3$167
Amneal Pharmaceuticals LLC13$165
Avanir Pharmaceuticals, Inc.9$165
Sumitomo Pharma America, Inc.7$164
Kowa Pharmaceuticals America, Inc.11$156
Esperion Therapeutics, Inc.7$153
Evoke Pharma, Inc.4$146
Neurocrine Biosciences, Inc.6$126
Alnylam Pharmaceuticals Inc.6$123
Idorsia Pharmaceuticals US Inc7$121
Collegium Pharmaceutical, Inc.8$120
Lupin Inc.1$119
Takeda Pharmaceuticals U.S.A., Inc.5$118
Scilex Pharmaceuticals Inc.5$113
Adlon Therapeutics L.p.5$110
Xeris Pharmaceuticals, Inc.7$108
Optinose US, Inc.4$88
Vanda Pharmaceuticals Inc.3$76
Sanofi Pasteur Inc.4$70
Almatica Pharma LLC4$67
Halozyme Inc3$63
Aytu Biopharma, Inc.3$47
Sunovion Pharmaceuticals Inc.3$46

How this compares

$106,600 in reported general payments places this provider in the 95th percentile of 588 family medicine providers in Connecticut.

See all family medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$153,055
Medicare patients
226
Services billed
2,557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in South Windsor

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →